You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,258,808


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,258,808
Title: Pharmaceutical composition
Abstract:Pharmaceutical compositions comprising a cyclosporin in a novel galenic formulations for oral administration. The compositions typically comprise a cyclosporin, 1,2-propylene glycol, a mixed mono-,di- and tri-glyceride and a hydrophilic surfactant. Further a refined glycerol-transesterified corn oil is provided representing a mixed mono-, di- and tri-glyceride suitable for the novel formulation. Dosage forms include in particular oral dosage forms.
Inventor(s): Hauer; Birgit (Lahr, DE), Meinzer; Armin (Freiburg-Munzingen, DE), Posanski; Ulrich (Freiburg, DE), Vonderscher; Jacky (Riedisheim, FR)
Assignee: Novartis AG (Basel, CH)
Application Number:09/690,400
Patent Claim Types:
see list of patent claims
Composition; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 6,258,808: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, patent holders, and those interested in the intellectual property landscape. This article will delve into the specifics of United States Patent 6,258,808, exploring its claims, the patent landscape, and relevant legal and procedural aspects.

What is United States Patent 6,258,808?

To begin, it is essential to identify the subject matter of the patent. However, without specific details provided in the query, we will use general principles to analyze the scope and claims of any patent, using this patent as a hypothetical example.

Patent Claims: Definition and Importance

Patent claims are the heart of a patent application, defining the scope of the invention for which protection is sought. These claims must be clear, concise, and fully supported by the description in the patent specification[2].

Types of Claims

  • Independent Claims: These stand alone and define the invention without reference to other claims.
  • Dependent Claims: These refer back to and further limit an independent claim.
  • Method Claims: Describe a process or method.
  • Apparatus Claims: Describe a device or system.

Claim Clarity and Quality

The clarity and quality of patent claims are critical. The USPTO has emphasized the importance of claim clarity through its Enhanced Patent Quality Initiative. This includes using tools like glossaries of terms and claim charts to ensure that claims are clear and understandable[1].

Determining Inventorship

Before diving into the claims, it is vital to ensure that the inventors listed on the patent are the true and only inventors. In the U.S., inventorship is determined by identifying those who conceived the idea or subject matter of the patent claims. Conception is defined as the formation in the mind of the inventor of a definite and permanent idea of the complete and operative invention[2].

Analyzing the Patent Landscape

The patent landscape includes all relevant patents and patent applications in a particular field. For a patent like 6,258,808, analyzing this landscape involves:

Classification Systems

Patent offices use classification systems to categorize patents. For example, the USPTO uses a cross-reference-art collection class for specific technologies like nanotechnology (class 977)[4].

Keyword Searches and Expert Consultations

Identifying relevant patents often involves keyword searches and consultations with experts in the field. This helps in understanding the trends and developments within the specific technology area[4].

The Role of the USPTO

The U.S. Patent and Trademark Office (USPTO) plays a central role in granting patents and ensuring their quality.

Enhanced Patent Quality Initiative

The USPTO has implemented various initiatives to improve patent quality. This includes defining patent quality consistently, reassessing examination times, and analyzing the effects of incentives on patent quality[1].

Correctness Measures and Compliance Targets

The USPTO calculates correctness measures and sets compliance targets to ensure that patents meet statutory requirements. These measures are based on reviews of randomly-selected Office actions and are publicly available[1].

Legal and Procedural Aspects

Statutory Requirements

Patent claims must meet statutory requirements such as novelty (35 U.S.C. § 102), non-obviousness (35 U.S.C. § 103), and utility (35 U.S.C. § 101). The claims must also be clear and definite (35 U.S.C. § 112)[2].

Court Decisions and Appeals

The Court of Appeals for the Federal Circuit often addresses issues related to patent claims and inventorship. These decisions can significantly impact how patents are interpreted and enforced[2].

Data and Research Datasets

For a detailed analysis, researchers can use datasets provided by the USPTO, such as the Patent Claims Research Dataset. This dataset contains detailed information on claims from U.S. patents and applications, which can help in understanding the scope and trends in patent claims[3].

Practical Steps for Analyzing a Patent

Review the Patent Specification

The patent specification provides the detailed description of the invention. It is essential to review this section to understand the context of the claims.

Identify Independent and Dependent Claims

Distinguish between independent and dependent claims to understand the core invention and its variations.

Analyze Claim Language

Ensure that the claim language is clear and concise. Look for any ambiguities or potential issues that could affect the enforceability of the patent.

Consult Expert Opinions

Consult with patent attorneys or experts in the field to get a comprehensive understanding of the patent's scope and potential challenges.

Key Takeaways

  • Clear Claims: Ensure that patent claims are clear, concise, and fully supported by the patent specification.
  • Inventorship: Correctly identify the true and only inventors to avoid legal challenges.
  • Patent Landscape: Analyze the broader patent landscape to understand the position of the patent within its field.
  • USPTO Initiatives: Be aware of USPTO initiatives aimed at improving patent quality.
  • Statutory Compliance: Ensure that the patent meets all statutory requirements.

FAQs

Q: What is the importance of claim clarity in a patent?

A: Claim clarity is crucial as it defines the scope of the invention and ensures that the patent is enforceable. Clear claims help in avoiding ambiguities and potential legal challenges.

Q: How is inventorship determined in U.S. patent law?

A: Inventorship is determined by identifying those who conceived the idea or subject matter of the patent claims. Conception is defined as the formation in the mind of the inventor of a definite and permanent idea of the complete and operative invention[2].

Q: What role does the USPTO play in ensuring patent quality?

A: The USPTO implements various initiatives such as the Enhanced Patent Quality Initiative, reassesses examination times, and analyzes the effects of incentives on patent quality to ensure high-quality patents[1].

Q: How can one analyze the patent landscape for a specific patent?

A: Analyzing the patent landscape involves using classification systems, keyword searches, and consulting with experts in the field to understand the trends and developments within the specific technology area[4].

Q: What are the statutory requirements for patent claims?

A: Patent claims must meet statutory requirements such as novelty (35 U.S.C. § 102), non-obviousness (35 U.S.C. § 103), and utility (35 U.S.C. § 101), and must also be clear and definite (35 U.S.C. § 112)[2].

Sources

  1. GAO Report: Intellectual Property: Patent Office Should Define Quality, Reassess Time Allotted for Examination, and Analyze Effects of Incentives on Patent Quality. GAO-16-490, June 30, 2016.
  2. Oregon State University: Determining Inventorship for US Patent Applications. agsci.oregonstate.edu.
  3. USPTO: Patent Claims Research Dataset. USPTO Economic Working Paper 2016-04.
  4. OECD: Capturing Nanotechnology's Current State of Development via Patent Analysis. OECD Publishing, 2007.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,258,808

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,258,808

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9113872Jun 27, 1991

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.